Psychopharmacology Maastricht
The psychopharmacology department at Maastricht University focuses on the cognitive, behavioral, and biological effects of various substances, ranging from pharmaceutical to recreational drugs.
Learn More
Natasha Mason and Zeus Tipado will be presenting at ICPR 2024 in Haarlem, Netherlands this June!
Maastricht Psychedelic Symposium
On May 24, the Maastricht Psychedelic Research Team will organize a mini-symposium on psychedelics. We will welcome two international speakers: Prof. dos Santos and Prof. Bouso from Brazil and Spain to discuss their ayahuasca and ibogaine research. We also have several internal speakers: presenting on mystical vs. autobiographical psychedelic experiences (Dr Kangaslampi), microdosing (Ms. Haijen), and 5-MeO-DMT (Mr. Reckweg). All students and staff with an interest in this topic are welcome to join us in the Maastrichtzaal in UNS40 between 13:30-15:30.
If you can’t make it, a live stream will be available at the link below!
Read about our new paper on the neurological origins of a visual psychedelic hallucination
Congratulations to Zeus Tipado on his newly published paper that introduces a new theory as to why a person experiences a visual trip on psychedelics.
Read The PaperParticipate in our studies!
We're always conducting research in our department and we're frequently looking for participants to be a part of science! If you're interested, look at the studies that we are currently conducting.
View All Studies
Our Scientists
Dr. Natasha Mason
Psychedelics, Neuroadaptations, Plasticity
My research is driven by my desire to find effective treatments for psychiatric disorders, particularly anxiety, depression, and post-traumatic stress disorder.
Aedan O’Shea, MSc
I have a long standing interest in unravelling the therapeutic mechanisms of Psychedelics, and in this project I will investigate the effect of Psychedelic drug exposure in humans on miRNA’s transported in neuron-derived Extracellular Vesicles...
Giordano Rossi, MSc
Depression, Ayahuasca, Esketamine
We are also evaluating subjective effects, safety, tolerability, and possible changes in personality, social cognition and well-being.
Prof. Arjan Blokland
Cognition, Learning & Memory, Acetylcholine
I studied Psychology at the Radboud University (Nijmegen, NL). After receiving my PhD in Maastricht in 1992, I did a post doc at the University of Cambridge in 1992.
Dr. Lilian Kloft
Drugs, False Memory, Cognition
I am a postdoctoral researcher in the fields of psychopharmacology and forensic psychology with an international education from various high-class universities.
Katharina Lege, MSc
Cannabinoids, Neuroimaging, Consciousness
Coming from a background of psychology and clinical neuroscience, I developed a strong interest in altered states of the mind as in mediation or yoga practices.
Zeus Tipado, MSc
My neuroscience research is focused on perceptual experiences of psychedelics, specifically visual experiences while under DMT.
Johannes Reckweg, MSc
5-MeO-DMT, Neuropsychopharmacology, Therapy
I am Johannes, a PhD candidate from Germany. After receiving my Bachelor’s degree from the Rijksuniversiteit Groningen, I came to Maastricht for my Master in Neuropsychology.
Mauro Cavarra, MSc
Psychosomatics, Chronic Pain, Psychedelic-Assisted Psychotherapy
I am a psychotherapist, hypnotherapist and clinical trainer interested in understanding the connection between mind and body. At the Department I work in research projects that explore the potential of psychedelic therapies in the treatment...
Psychedelic Research
Trait mindfulness and personality characteristics in a microdosing ADHD sample: a naturalistic prospective survey study
→
Psilocybin induces acute and persisting alterations in immune status and the stress response in healthy volunteers
→
Improving cognitive functioning in major depressive disorder with psychedelics: A dimensional approach
→
The use patterns of novel psychedelics: experiential fingerprints of substituted phenethylamines, tryptamines and lysergamides
→
Microdosing with psychedelics to self-medicate for ADHD symptoms in adults: A prospective naturalistic study
→
Cannabis Research
Cognition and motor control as a function of 9-THC concentration in serum and oral fluid: Limits of impairment
→
Comparison of Cannabinoid Pharmacokinetic Properties in Occasional and Heavy Users Smoking a Marijuana or Placebo Joint
→
Rivastigmine but not vardenafil reverses cannabis-induced impairment of verbal memory in healthy humans
→
Cannabis induced increase in striatal glutamate associated with loss of functional corticostriatal connectivity
Glutamate, Functional Connectivity, Cannabis
→
Get in Touch
We are always up for communicating with people that have interesting ideas or questions. If you want to contact our department, please reach out using this form below.